76 related articles for article (PubMed ID: 19585453)
1. Preparation and evaluation of [(61)Cu]-thiophene-2-aldehyde thiosemicarbazone for PET studies.
Jalilian AR; Nikzad M; Zandi H; Kharat AN; Rowshanfarzad P; Akhlaghi M; Bolourinovin F
Nucl Med Rev Cent East Eur; 2008; 11(2):41-7. PubMed ID: 19585453
[TBL] [Abstract][Full Text] [Related]
2. Preparation of [61Cu]-2-acetylpyridine thiosemicarbazone complex as a possible PET tracer for malignancies.
Jalilian AR; Rowshanfarzad P; Sabet M; Shafiee A
Appl Radiat Isot; 2006 Mar; 64(3):337-41. PubMed ID: 16293418
[TBL] [Abstract][Full Text] [Related]
3. Preclinical studies of [61Cu]ATSM as a PET radiopharmaceutical for fibrosarcoma imaging.
Jalilian AR; Rostampour N; Rowshanfarzad P; Shafaii K; Kamali-Dehghan M; Akhlaghi M
Acta Pharm; 2009 Mar; 59(1):45-55. PubMed ID: 19304557
[TBL] [Abstract][Full Text] [Related]
4. Preparation and preliminary evaluation of 63Zn-zinc citrate as a novel PET imaging biomarker for zinc.
DeGrado TR; Pandey MK; Byrne JF; Engelbrecht HP; Jiang H; Packard AB; Thomas KA; Jacobson MS; Curran GL; Lowe VJ
J Nucl Med; 2014 Aug; 55(8):1348-54. PubMed ID: 25047329
[TBL] [Abstract][Full Text] [Related]
5. Production and tumour uptake of [64Cu]Pyruvaldehyde-bis (N4-methylthiosemicarbazone) for PET and/or therapeutic purposes.
Jalilian AR; Rowshanfarzad P; Kamrani YY; Shafaii K; Mirzaii M
Nucl Med Rev Cent East Eur; 2007; 10(1):6-11. PubMed ID: 17694494
[TBL] [Abstract][Full Text] [Related]
6. 64Cu-azabicyclo[3.2.2]nonane thiosemicarbazone complexes: radiopharmaceuticals for PET of topoisomerase II expression in tumors.
Wei L; Easmon J; Nagi RK; Muegge BD; Meyer LA; Lewis JS
J Nucl Med; 2006 Dec; 47(12):2034-41. PubMed ID: 17138747
[TBL] [Abstract][Full Text] [Related]
7. The development of radiogallium-acetylacetonate bis(thiosemicarbazone) complex for tumour imaging.
Jalilian AR; Yousefnia H; Garousi J; Novinrouz A; Rajamand AA; Shafaee K
Nucl Med Rev Cent East Eur; 2009; 12(2):65-71. PubMed ID: 20235056
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of [(201)Tl](III) Vancomycin in normal rats.
Jalilian AR; Hosseini MA; Majdabadi A; Saddadi F
Nucl Med Rev Cent East Eur; 2008; 11(1):1-4. PubMed ID: 19173180
[TBL] [Abstract][Full Text] [Related]
9. A kit formulation for the preparation of 188Re-lipiodol: preclinical studies and preliminary therapeutic evaluation in patients with unresectable hepatocellular carcinoma.
Boschi A; Uccelli L; Duatti A; Colamussi P; Cittanti C; Filice A; Rose AH; Martindale AA; Claringbold PG; Kearney D; Galeotti R; Turner JH; Giganti M
Nucl Med Commun; 2004 Jul; 25(7):691-9. PubMed ID: 15208496
[TBL] [Abstract][Full Text] [Related]
10. Comparative in vivo behavior studies of cyclen-based copper-64 complexes: regioselective synthesis, X-ray structure, radiochemistry, log P, and biodistribution.
Yoo J; Reichert DE; Welch MJ
J Med Chem; 2004 Dec; 47(26):6625-37. PubMed ID: 15588098
[TBL] [Abstract][Full Text] [Related]
11. An improved synthesis and biological evaluation of a new cage-like bifunctional chelator, 4-((8-amino-3,6,10,13,16,19-hexaazabicyclo[6.6.6]icosane-1-ylamino)methyl)benzoic acid, for 64Cu radiopharmaceuticals.
Cai H; Li Z; Huang CW; Park R; Shahinian AH; Conti PS
Nucl Med Biol; 2010 Jan; 37(1):57-65. PubMed ID: 20122669
[TBL] [Abstract][Full Text] [Related]
12. A novel neutrophil-specific PET imaging agent: cFLFLFK-PEG-64Cu.
Locke LW; Chordia MD; Zhang Y; Kundu B; Kennedy D; Landseadel J; Xiao L; Fairchild KD; Berr SS; Linden J; Pan D
J Nucl Med; 2009 May; 50(5):790-7. PubMed ID: 19372473
[TBL] [Abstract][Full Text] [Related]
13. Radiolabelling and biodistribution of 111In-antimony trisulphide colloid.
Tsopelas C; Cooper R
Hell J Nucl Med; 2005; 8(2):109-12. PubMed ID: 16142252
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of dopamine D3 receptor antagonist 11C-GR218231 as PET tracer for P-glycoprotein.
de Vries EF; Kortekaas R; van Waarde A; Dijkstra D; Elsinga PH; Vaalburg W
J Nucl Med; 2005 Aug; 46(8):1384-92. PubMed ID: 16085598
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and Evaluation of New Generation Cross-Bridged Bifunctional Chelator for (64)Cu Radiotracers.
Dale AV; An GI; Pandya DN; Ha YS; Bhatt N; Soni N; Lee H; Ahn H; Sarkar S; Lee W; Huynh PT; Kim JY; Gwon MR; Kim SH; Park JG; Yoon YR; Yoo J
Inorg Chem; 2015 Sep; 54(17):8177-86. PubMed ID: 26286436
[TBL] [Abstract][Full Text] [Related]
16. (99m)Tc human IgG radiolabelled by HYNIC. Biodistribution and scintigraphy of experimentally induced inflammatory lesions in animal model.
Karczmarczyk U; Markiewicz A; Mikołajczak R; Lisiak E; Bilski M; Pietrzykowski J; Michalik J
Nucl Med Rev Cent East Eur; 2004; 7(2):107-12. PubMed ID: 15968595
[TBL] [Abstract][Full Text] [Related]
17. In vivo behavior of copper-64-labeled methanephosphonate tetraaza macrocyclic ligands.
Sun X; Wuest M; Kovacs Z; Sherry AD; Motekaitis R; Wang Z; Martell AE; Welch MJ; Anderson CJ
J Biol Inorg Chem; 2003 Jan; 8(1-2):217-25. PubMed ID: 12459917
[TBL] [Abstract][Full Text] [Related]
18. Comparison of whole-body PET/CT and PET/MRI in breast cancer patients: lesion detection and quantitation of 18F-deoxyglucose uptake in lesions and in normal organ tissues.
Pace L; Nicolai E; Luongo A; Aiello M; Catalano OA; Soricelli A; Salvatore M
Eur J Radiol; 2014 Feb; 83(2):289-96. PubMed ID: 24331845
[TBL] [Abstract][Full Text] [Related]
19. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
[TBL] [Abstract][Full Text] [Related]
20. 111In-LLP2A-DOTA Polyethylene Glycol-Targeting {alpha}4{beta}1 Integrin: Comparative Pharmacokinetics for Imaging and Therapy of Lymphoid Malignancies.
Denardo SJ; Liu R; Albrecht H; Natarajan A; Sutcliffe JL; Anderson C; Peng L; Ferdani R; Cherry SR; Lam KS
J Nucl Med; 2009 Apr; 50(4):625-34. PubMed ID: 19289419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
